InMode Q3 2026 Revenue Hits $92.1M, Full-Year Outlook Held
InMode reported $92.1 million in GAAP revenue for Q3 2026 and reaffirmed its full-year financial guidance.
InMode Ltd., the Nasdaq-listed medical technology company headquartered in Yokneam, Israel, posted third-quarter 2026 GAAP revenues of $92.1 million, the company announced Wednesday. Management simultaneously reaffirmed its full-year 2026 financial outlook, signaling confidence in the trajectory of its core business despite broader market pressures facing the medical aesthetics sector.
The quarterly results mark a continued effort by InMode to maintain financial stability as the company navigates shifting demand patterns for minimally invasive medical technologies. InMode markets its platforms globally, positioning itself as a provider of energy-based solutions used by physicians across aesthetic and wellness applications.
Read more Direxion Partners With Pompliano's Silvia on Income Investing Education →
By reaffirming annual guidance alongside the quarterly release, InMode's leadership signaled that the third-quarter performance was broadly in line with internal expectations. Such guidance reaffirmations are closely watched by investors as indicators of management visibility into near-term demand and capital equipment sales cycles.
The medical technology sector has faced headwinds including cautious physician capital spending and macroeconomic uncertainty affecting elective procedure volumes. InMode's ability to hold its full-year outlook intact may offer some reassurance to analysts monitoring the competitive landscape in aesthetic devices.
Continue reading at Earnings for the full breakdown of InMode's Q3 2026 financial results, including non-GAAP metrics and forward guidance details.